These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 11719467

  • 1. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 2. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec 15; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 3. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 4. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 5. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.
    Invest Ophthalmol Vis Sci; 2010 Feb 01; 51(2):679-85. PubMed ID: 19737884
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 7. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun 15; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 8. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
    de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Oncol Res; 1997 Jun 15; 9(2):89-98. PubMed ID: 9167190
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K, Ahmed MM, Mohiuddin M, Swiderski C, Lee E, Gower WR, Salhab KF, McGrath P, Strodel W, Freeman JW.
    Anticancer Res; 2000 Jun 15; 20(1A):43-51. PubMed ID: 10769633
    [Abstract] [Full Text] [Related]

  • 10. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N, Roberts AB, Birkey Reffey S, Miyazono K, Itoh S, ten Dijke P, Heiss EH, Place AE, Risingsong R, Williams CR, Honda T, Gribble GW, Sporn MB.
    Cancer Res; 2003 Mar 15; 63(6):1371-6. PubMed ID: 12649201
    [Abstract] [Full Text] [Related]

  • 11. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M, Kurosaki H, Sairenji T.
    J Med Virol; 2006 Nov 15; 78(11):1456-64. PubMed ID: 16998876
    [Abstract] [Full Text] [Related]

  • 12. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N, Perrais M, Mariette C, Batra SK, Aubert JP, Pigny P, Van Seuningen I.
    Oncogene; 2004 Jul 29; 23(34):5729-38. PubMed ID: 15184872
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A, Uematsu K, Hagiwara K, Takenoshita S, Kudoh S.
    Gan To Kagaku Ryoho; 2000 Jul 29; 27(8):1253-9. PubMed ID: 10945024
    [Abstract] [Full Text] [Related]

  • 14. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 29; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 15. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.
    Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ.
    Cell Growth Differ; 2001 Jan 07; 12(1):9-18. PubMed ID: 11205746
    [Abstract] [Full Text] [Related]

  • 17. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE, Roberts AB.
    Cancer Res; 2004 Jul 01; 64(13):4523-30. PubMed ID: 15231662
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
    Baugé C, Legendre F, Leclercq S, Elissalde JM, Pujol JP, Galéra P, Boumédiene K.
    Arthritis Rheum; 2007 Sep 01; 56(9):3020-32. PubMed ID: 17763417
    [Abstract] [Full Text] [Related]

  • 19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 20. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH, Kim YS, Park BK, Hougaard S, Kim SJ.
    Oncogene; 2001 Mar 08; 20(10):1235-45. PubMed ID: 11313868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.